Report Cover

Global and Japan Nuclear Cardiology Market Size, Status and Forecast 2021-2027


Global Nuclear Cardiology Scope and Market Size
Nuclear Cardiology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Cardiology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
    Radiology Devices
    Radiology Information Systems (RIS)
    Radiopharmaceuticals

Segment by Application
    Hospitals
    Clinics
    Academic and Research Institutes
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

By Company
    GE Healthcare
    Shimadzu
    Siemens Healthcare
    Fujifilm Medical
    Astellas Pharma
    Philips Healthcare
    Medtronic
    3mensio Medical Imaging
    Bracco Diagnostics
    UltraSPECT
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Nuclear Cardiology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Radiology Devices
        1.2.3 Radiology Information Systems (RIS)
        1.2.4 Radiopharmaceuticals
    1.3 Market by Application
        1.3.1 Global Nuclear Cardiology Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Academic and Research Institutes
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Nuclear Cardiology Market Perspective (2016-2027)
    2.2 Nuclear Cardiology Growth Trends by Regions
        2.2.1 Nuclear Cardiology Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Nuclear Cardiology Historic Market Share by Regions (2016-2021)
        2.2.3 Nuclear Cardiology Forecasted Market Size by Regions (2022-2027)
    2.3 Nuclear Cardiology Industry Dynamic
        2.3.1 Nuclear Cardiology Market Trends
        2.3.2 Nuclear Cardiology Market Drivers
        2.3.3 Nuclear Cardiology Market Challenges
        2.3.4 Nuclear Cardiology Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Nuclear Cardiology Players by Revenue
        3.1.1 Global Top Nuclear Cardiology Players by Revenue (2016-2021)
        3.1.2 Global Nuclear Cardiology Revenue Market Share by Players (2016-2021)
    3.2 Global Nuclear Cardiology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Nuclear Cardiology Revenue
    3.4 Global Nuclear Cardiology Market Concentration Ratio
        3.4.1 Global Nuclear Cardiology Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Nuclear Cardiology Revenue in 2020
    3.5 Nuclear Cardiology Key Players Head office and Area Served
    3.6 Key Players Nuclear Cardiology Product Solution and Service
    3.7 Date of Enter into Nuclear Cardiology Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Nuclear Cardiology Breakdown Data by Type
    4.1 Global Nuclear Cardiology Historic Market Size by Type (2016-2021)
    4.2 Global Nuclear Cardiology Forecasted Market Size by Type (2022-2027)

5 Nuclear Cardiology Breakdown Data by Application
    5.1 Global Nuclear Cardiology Historic Market Size by Application (2016-2021)
    5.2 Global Nuclear Cardiology Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Nuclear Cardiology Market Size (2016-2027)
    6.2 North America Nuclear Cardiology Market Size by Type
        6.2.1 North America Nuclear Cardiology Market Size by Type (2016-2021)
        6.2.2 North America Nuclear Cardiology Market Size by Type (2022-2027)
        6.2.3 North America Nuclear Cardiology Market Size by Type (2016-2027)
    6.3 North America Nuclear Cardiology Market Size by Application
        6.3.1 North America Nuclear Cardiology Market Size by Application (2016-2021)
        6.3.2 North America Nuclear Cardiology Market Size by Application (2022-2027)
        6.3.3 North America Nuclear Cardiology Market Size by Application (2016-2027)
    6.4 North America Nuclear Cardiology Market Size by Country
        6.4.1 North America Nuclear Cardiology Market Size by Country (2016-2021)
        6.4.2 North America Nuclear Cardiology Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Nuclear Cardiology Market Size (2016-2027)
    7.2 Europe Nuclear Cardiology Market Size by Type
        7.2.1 Europe Nuclear Cardiology Market Size by Type (2016-2021)
        7.2.2 Europe Nuclear Cardiology Market Size by Type (2022-2027)
        7.2.3 Europe Nuclear Cardiology Market Size by Type (2016-2027)
    7.3 Europe Nuclear Cardiology Market Size by Application
        7.3.1 Europe Nuclear Cardiology Market Size by Application (2016-2021)
        7.3.2 Europe Nuclear Cardiology Market Size by Application (2022-2027)
        7.3.3 Europe Nuclear Cardiology Market Size by Application (2016-2027)
    7.4 Europe Nuclear Cardiology Market Size by Country
        7.4.1 Europe Nuclear Cardiology Market Size by Country (2016-2021)
        7.4.2 Europe Nuclear Cardiology Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Nuclear Cardiology Market Size (2016-2027)
    8.2 Asia-Pacific Nuclear Cardiology Market Size by Type
        8.2.1 Asia-Pacific Nuclear Cardiology Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Nuclear Cardiology Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Nuclear Cardiology Market Size by Type (2016-2027)
    8.3 Asia-Pacific Nuclear Cardiology Market Size by Application
        8.3.1 Asia-Pacific Nuclear Cardiology Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Nuclear Cardiology Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Nuclear Cardiology Market Size by Application (2016-2027)
    8.4 Asia-Pacific Nuclear Cardiology Market Size by Region
        8.4.1 Asia-Pacific Nuclear Cardiology Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Nuclear Cardiology Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Nuclear Cardiology Market Size (2016-2027)
    9.2 Latin America Nuclear Cardiology Market Size by Type
        9.2.1 Latin America Nuclear Cardiology Market Size by Type (2016-2021)
        9.2.2 Latin America Nuclear Cardiology Market Size by Type (2022-2027)
        9.2.3 Latin America Nuclear Cardiology Market Size by Type (2016-2027)
    9.3 Latin America Nuclear Cardiology Market Size by Application
        9.3.1 Latin America Nuclear Cardiology Market Size by Application (2016-2021)
        9.3.2 Latin America Nuclear Cardiology Market Size by Application (2022-2027)
        9.3.3 Latin America Nuclear Cardiology Market Size by Application (2016-2027)
    9.4 Latin America Nuclear Cardiology Market Size by Country
        9.4.1 Latin America Nuclear Cardiology Market Size by Country (2016-2021)
        9.4.2 Latin America Nuclear Cardiology Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Nuclear Cardiology Market Size (2016-2027)
    10.2 Middle East & Africa Nuclear Cardiology Market Size by Type
        10.2.1 Middle East & Africa Nuclear Cardiology Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Nuclear Cardiology Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Nuclear Cardiology Market Size by Type (2016-2027)
    10.3 Middle East & Africa Nuclear Cardiology Market Size by Application
        10.3.1 Middle East & Africa Nuclear Cardiology Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Nuclear Cardiology Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Nuclear Cardiology Market Size by Application (2016-2027)
    10.4 Middle East & Africa Nuclear Cardiology Market Size by Country
        10.4.1 Middle East & Africa Nuclear Cardiology Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Nuclear Cardiology Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 GE Healthcare
        11.1.1 GE Healthcare Company Details
        11.1.2 GE Healthcare Business Overview
        11.1.3 GE Healthcare Nuclear Cardiology Introduction
        11.1.4 GE Healthcare Revenue in Nuclear Cardiology Business (2016-2021)
        11.1.5 GE Healthcare Recent Development
    11.2 Shimadzu
        11.2.1 Shimadzu Company Details
        11.2.2 Shimadzu Business Overview
        11.2.3 Shimadzu Nuclear Cardiology Introduction
        11.2.4 Shimadzu Revenue in Nuclear Cardiology Business (2016-2021)
        11.2.5 Shimadzu Recent Development
    11.3 Siemens Healthcare
        11.3.1 Siemens Healthcare Company Details
        11.3.2 Siemens Healthcare Business Overview
        11.3.3 Siemens Healthcare Nuclear Cardiology Introduction
        11.3.4 Siemens Healthcare Revenue in Nuclear Cardiology Business (2016-2021)
        11.3.5 Siemens Healthcare Recent Development
    11.4 Fujifilm Medical
        11.4.1 Fujifilm Medical Company Details
        11.4.2 Fujifilm Medical Business Overview
        11.4.3 Fujifilm Medical Nuclear Cardiology Introduction
        11.4.4 Fujifilm Medical Revenue in Nuclear Cardiology Business (2016-2021)
        11.4.5 Fujifilm Medical Recent Development
    11.5 Astellas Pharma
        11.5.1 Astellas Pharma Company Details
        11.5.2 Astellas Pharma Business Overview
        11.5.3 Astellas Pharma Nuclear Cardiology Introduction
        11.5.4 Astellas Pharma Revenue in Nuclear Cardiology Business (2016-2021)
        11.5.5 Astellas Pharma Recent Development
    11.6 Philips Healthcare
        11.6.1 Philips Healthcare Company Details
        11.6.2 Philips Healthcare Business Overview
        11.6.3 Philips Healthcare Nuclear Cardiology Introduction
        11.6.4 Philips Healthcare Revenue in Nuclear Cardiology Business (2016-2021)
        11.6.5 Philips Healthcare Recent Development
    11.7 Medtronic
        11.7.1 Medtronic Company Details
        11.7.2 Medtronic Business Overview
        11.7.3 Medtronic Nuclear Cardiology Introduction
        11.7.4 Medtronic Revenue in Nuclear Cardiology Business (2016-2021)
        11.7.5 Medtronic Recent Development
    11.8 3mensio Medical Imaging
        11.8.1 3mensio Medical Imaging Company Details
        11.8.2 3mensio Medical Imaging Business Overview
        11.8.3 3mensio Medical Imaging Nuclear Cardiology Introduction
        11.8.4 3mensio Medical Imaging Revenue in Nuclear Cardiology Business (2016-2021)
        11.8.5 3mensio Medical Imaging Recent Development
    11.9 Bracco Diagnostics
        11.9.1 Bracco Diagnostics Company Details
        11.9.2 Bracco Diagnostics Business Overview
        11.9.3 Bracco Diagnostics Nuclear Cardiology Introduction
        11.9.4 Bracco Diagnostics Revenue in Nuclear Cardiology Business (2016-2021)
        11.9.5 Bracco Diagnostics Recent Development
    11.10 UltraSPECT
        11.10.1 UltraSPECT Company Details
        11.10.2 UltraSPECT Business Overview
        11.10.3 UltraSPECT Nuclear Cardiology Introduction
        11.10.4 UltraSPECT Revenue in Nuclear Cardiology Business (2016-2021)
        11.10.5 UltraSPECT Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Nuclear Cardiology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Radiology Devices Table 3. Key Players of Radiology Information Systems (RIS) Table 4. Key Players of Radiopharmaceuticals Table 5. Global Nuclear Cardiology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Nuclear Cardiology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Nuclear Cardiology Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Nuclear Cardiology Market Share by Regions (2016-2021) Table 9. Global Nuclear Cardiology Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Nuclear Cardiology Market Share by Regions (2022-2027) Table 11. Nuclear Cardiology Market Trends Table 12. Nuclear Cardiology Market Drivers Table 13. Nuclear Cardiology Market Challenges Table 14. Nuclear Cardiology Market Restraints Table 15. Global Nuclear Cardiology Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Nuclear Cardiology Market Share by Players (2016-2021) Table 17. Global Top Nuclear Cardiology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Cardiology as of 2020) Table 18. Ranking of Global Top Nuclear Cardiology Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Nuclear Cardiology Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Nuclear Cardiology Product Solution and Service Table 22. Date of Enter into Nuclear Cardiology Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Nuclear Cardiology Market Size by Type (2016-2021) (US$ Million) Table 25. Global Nuclear Cardiology Revenue Market Share by Type (2016-2021) Table 26. Global Nuclear Cardiology Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Nuclear Cardiology Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Nuclear Cardiology Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Nuclear Cardiology Revenue Market Share by Application (2016-2021) Table 30. Global Nuclear Cardiology Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Nuclear Cardiology Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Nuclear Cardiology Market Size by Type (2016-2021) (US$ Million) Table 33. North America Nuclear Cardiology Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Nuclear Cardiology Market Size by Application (2016-2021) (US$ Million) Table 35. North America Nuclear Cardiology Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Nuclear Cardiology Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Nuclear Cardiology Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Nuclear Cardiology Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Nuclear Cardiology Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Nuclear Cardiology Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Nuclear Cardiology Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Nuclear Cardiology Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Nuclear Cardiology Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Nuclear Cardiology Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Nuclear Cardiology Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Nuclear Cardiology Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Nuclear Cardiology Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Nuclear Cardiology Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Nuclear Cardiology Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Nuclear Cardiology Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Nuclear Cardiology Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Nuclear Cardiology Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Nuclear Cardiology Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Nuclear Cardiology Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Nuclear Cardiology Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Nuclear Cardiology Market Size by Type (2016-2021) (US$ Mi

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us